v3.19.3
Consolidated Statements of Income - USD ($)
$ in Millions |
3 Months Ended |
9 Months Ended |
|
|
|
|
Net sales |
$ 10,764
|
$ 12,634
|
$ 32,747
|
$ 37,660
|
Cost of sales |
9,377
|
10,456
|
27,939
|
30,976
|
Research and development expenses |
194
|
193
|
592
|
622
|
Selling, general and administrative expenses |
388
|
409
|
1,258
|
1,376
|
Amortization of intangibles |
100
|
117
|
320
|
353
|
Restructuring and asset related charges - net |
147
|
48
|
368
|
175
|
Integration and separation costs |
164
|
313
|
964
|
799
|
Equity in earnings (losses) of nonconsolidated affiliates |
(44)
|
135
|
(73)
|
529
|
Sundry income (expense) - net |
301
|
(3)
|
369
|
37
|
Interest income |
19
|
22
|
58
|
60
|
Interest expense and amortization of debt discount |
233
|
258
|
711
|
781
|
Income from continuing operations before income taxes |
437
|
994
|
949
|
3,204
|
Provision for income taxes on continuing operations |
90
|
280
|
356
|
755
|
Income from continuing operations, net of tax |
347
|
714
|
593
|
2,449
|
Income from discontinued operations, net of tax |
0
|
335
|
445
|
1,403
|
Net income |
347
|
1,049
|
1,038
|
3,852
|
Net income attributable to noncontrolling interests |
14
|
36
|
74
|
102
|
Net income available for The Dow Chemical Company common stockholder |
333
|
1,013
|
964
|
3,750
|
Depreciation |
540
|
549
|
1,621
|
1,643
|
Capital expenditures |
472
|
577
|
1,384
|
1,445
|
The Dow Chemical Company [Domain] |
|
|
|
|
Net sales |
10,764
|
12,634
|
32,747
|
37,660
|
Cost of sales |
9,377
|
10,456
|
27,938
|
30,976
|
Research and development expenses |
194
|
193
|
592
|
622
|
Selling, general and administrative expenses |
389
|
409
|
1,255
|
1,376
|
Amortization of intangibles |
100
|
117
|
320
|
353
|
Restructuring and asset related charges - net |
147
|
48
|
368
|
175
|
Integration and separation costs |
164
|
313
|
940
|
799
|
Equity in earnings (losses) of nonconsolidated affiliates |
(44)
|
135
|
(73)
|
529
|
Sundry income (expense) - net |
284
|
(3)
|
462
|
37
|
Interest income |
19
|
22
|
58
|
60
|
Interest expense and amortization of debt discount |
238
|
258
|
728
|
781
|
Income from continuing operations before income taxes |
414
|
994
|
1,053
|
3,204
|
Provision for income taxes on continuing operations |
90
|
280
|
356
|
755
|
Income from continuing operations, net of tax |
324
|
714
|
697
|
2,449
|
Income from discontinued operations, net of tax |
0
|
335
|
445
|
1,403
|
Net income |
324
|
1,049
|
1,142
|
3,852
|
Net income attributable to noncontrolling interests |
14
|
36
|
74
|
102
|
Net income available for The Dow Chemical Company common stockholder |
310
|
1,013
|
1,068
|
3,750
|
Depreciation |
540
|
549
|
1,621
|
1,643
|
Capital expenditures |
$ 472
|
$ 577
|
$ 1,384
|
$ 1,445
|
X |
- DefinitionThe aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
+ Details
Name: |
us-gaap_AmortizationOfIntangibleAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ References
+ Details
Name: |
us-gaap_CostOfGoodsAndServicesSold |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
+ Details
Name: |
us-gaap_Depreciation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount after tax of income (loss) from continuing operations attributable to the parent.
+ References
+ Details
Name: |
us-gaap_IncomeLossFromContinuingOperations |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
+ References
+ Details
Name: |
us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of income (loss) for proportionate share of equity method investee's income (loss).
+ References
+ Details
Name: |
us-gaap_IncomeLossFromEquityMethodInvestments |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of the cost of borrowed funds accounted for as interest expense for debt.
+ References
+ Details
Name: |
us-gaap_InterestExpenseDebt |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of interest income earned from interest bearing assets classified as other.
+ References
+ Details
Name: |
us-gaap_InterestIncomeOther |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of Net Income (Loss) attributable to noncontrolling interest.
+ References
+ Details
Name: |
us-gaap_NetIncomeLossAttributableToNoncontrollingInterest |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
+ Details
Name: |
us-gaap_NonoperatingIncomeExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.
+ References
+ Details
Name: |
us-gaap_PaymentsToAcquireProductiveAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
+ Details
Name: |
us-gaap_ProfitLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.
+ References
+ Details
Name: |
us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of restructuring charges, remediation cost, and asset impairment loss.
+ References
+ Details
Name: |
us-gaap_RestructuringSettlementAndImpairmentProvisions |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
+ References
+ Details
Name: |
us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
+ Details
Name: |
us-gaap_SellingGeneralAndAdministrativeExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- Details
Name: |
dei_LegalEntityAxis=dow_TheDowChemicalCompanyDomain |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
|